AMAG Pharmaceuticals Appoints Helen Milton, Ph.D. as Vice President of Regulatory Affairs
May 16, 2017 12:02 pm UTC| Business
WALTHAM, Mass., May 16, 2017 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Helen Milton, Ph.D., to the role of vice president of regulatory affairs. Dr. Milton will have responsibility...
North State Creates Integrated IT Services Business Unit
May 16, 2017 12:02 pm UTC| Business
HIGH POINT, N.C., May 16, 2017 -- North State, a leading fiber optic network, IT security, data center and cloud services provider, has created a new, integrated IT services business unit. The new business unit,...
North State Creates Integrated IT Services Business Unit
May 16, 2017 12:01 pm UTC| Business
HIGH POINT, N.C., May 16, 2017 -- North State, a leading fiber optic network, IT security, data center and cloud services provider, has created a new, integrated IT services business unit. The new business unit,...
Hooper Holmes and Provant Merger Creates Largest Pure-Play Well-Being Ecosystem
May 16, 2017 12:00 pm UTC| Business
Merger provides largest pure-play health well-being ecosystem for enhanced partner successStrength of the product offering and diversification of distribution channels accelerates innovation for existing customers and...
Altimmune Promotes Dr. Sybil Tasker to Chief Medical Officer
May 16, 2017 12:00 pm UTC| Business
GAITHERSBURG, Md., May 16, 2017 -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced the promotion of Sybil Tasker, M.D., FACP, FIDSA, to the position of Chief Medical Officer....
Lice Clinics of America Opens New Treatment Center in Falls Church
May 16, 2017 12:00 pm UTC| Business
Falls Church, Virginia, May 16, 2017 -- Head lice infamously cause stress, disgust and embarrassment for millions of parents whose kids get infested each year. But thanks to the opening of a new Lice Clinics of America...
May 16, 2017 11:59 am UTC| Business
PHILADELPHIA and OXFORD, U.K., May 16, 2017 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that it has initiated the first site for its MAGE‑A4 SPEAR T-cell...
Mother of All Deals: India & EU Seal Historic FTA After 20 Years